MeSH tree: C05.116.900.853.625.800.424
In his mid-teens during the 1970s, Maarten de Wit had severe joint pain in multiple parts of his body. He had to wait another three years until the age of 19 before being diagnosed with arthritis.
Feb 8, 2024
0
44
Men with inflammatory joint disease, such as rheumatoid arthritis, are less likely to be childless and have more children than their healthy peers, suggests research published online in the Annals of the Rheumatic Diseases.
Jan 22, 2024
0
49
Almost 30% of the patients in a pilot program for those with psoriasis that was devised by researchers from the Perelman School of Medicine at the University of Pennsylvania were identified as having undiagnosed, elevated ...
Jan 8, 2024
0
41
Research from Hospital for Special Surgery (HSS) reveals a significant psychological impact related to inflammatory arthritis patients' efforts to maintain employment while coping with the challenges of their illness. The ...
Nov 13, 2023
0
43
The U.S. Food and Drug Administration has approved Amgen's Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara (ustekinumab) for multiple inflammatory diseases.
Nov 3, 2023
0
56
Relief could be on the way for people with painful hand osteoarthritis after a Monash University and Alfred Health-led study found an affordable existing drug can help. Until now there has been no effective treatment.
Oct 13, 2023
0
390
Researchers from Keele University's School of Medicine have found that analgesic medicines—commonly known as "painkillers"—are widely prescribed to people with inflammatory arthritis across England despite little research ...
Oct 12, 2023
0
77
In the largest study to date exploring the relationship between severe psoriasis and coronary microvascular dysfunction, researchers have found further evidence that patients with severe psoriasis are at higher cardiovascular ...
Sep 20, 2023
0
79
Eczema and psoriasis are skin conditions that can each affect a person's quality of life.
Sep 8, 2023
0
118
A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient's ...
Sep 6, 2023
0
67
